Product How it works Pricing Blog FAQ About Contact
Nkarta

Nkarta (NASDAQ: NKTX) revenue

Nkarta reported revenue of $0.0m for fiscal 2025; in fiscal 2024 it was $0.0m.

Nkarta's best year of the last 3 was fiscal 2019.

Revenue, in millions of US dollars0.120190.020240.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$0.0m—−$122.0m—
2024$0.0m—−$128.2m—
2019$0.1m—−$22.3m−19,433.9%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Nkarta revenue compared with its sector

By revenue for its latest fiscal year, Nkarta ranks 412th of the 422 US health care companies with a page on Celsmar.

RankCompanyRevenueRevenue growth
410thMonopar Therapeutics$0.0m—
411thNeurogene$0.0m−100.0%
412thNkarta$0.0m—
413thPalisade Bio$0.0m—
414thPraxis Precision Medicines$0.0m−100.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Nkarta

How much revenue did Nkarta make in fiscal 2025?
Nkarta reported revenue of $0.0m for fiscal 2025, compared with $0.0m in fiscal 2024.
What was the best year for revenue at Nkarta?
Of its last 3 fiscal years, fiscal 2019, with $0.1m.
Where does Nkarta rank in its sector by revenue?
It ranks 412th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Nkarta come from?
From the annual report (Form 10-K) that Nkarta files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Nkarta files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2019. More on Nkarta: the Nkarta page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.